Elysium Therapeutics is a company that develops and provides disruptive pain therapies. It offers O2P, a platform that provides self-limiting exposure to active opioids and prevents overdose; XpiRx, a solution that reduces abuse and prevents fatal overdoses; and SOOPR, a synthetic opioid overdose prevention and rescue product.